TOMSON GROUP(00258)
Search documents
*ST围海(002586.SZ):签订3.13亿元重大合同
Ge Long Hui· 2025-11-20 11:01
格隆汇11月20日丨*ST围海(002586.SZ)公布,公司于2025年10月28日在巨潮资讯网刊登了《关于工程项 目中标的公告》,确定公司为"淮河入海水道二期工程(淮安市境内)河道工程施工14标"的中标单位。 目前,公司与相关方签署上述项目施工合同。签约合同价:312,956,420.04元。 ...
ST未名(002581.SZ)获得一类创新药重组人神经生长因子SMR001滴眼液III期临床试验伦理批件
智通财经网· 2025-11-06 11:13
Core Viewpoint - ST Unimed (002581.SZ) announced that its wholly-owned subsidiary, Shandong Yandu Biotechnology Co., Ltd., has received ethical approval from the Ethics Committee of Beijing Tongren Hospital, affiliated with Capital Medical University, to conduct a Phase III clinical trial for its innovative drug, recombinant human nerve growth factor SMR001 eye drops, aimed at treating moderate to severe dry eye syndrome [1] Summary by Categories Company Developments - The ethical approval for the Phase III clinical trial signifies that the project has met the necessary ethical compliance requirements to proceed [1] - The initiation of this clinical trial is not expected to have a significant impact on the company's operating performance in the short term [1]
汤臣集团(00258) - 截至二零二五年十月三十一日止之股份发行人的证券变动月报表
2025-11-04 08:44
FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 湯臣集團有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00258 | 說明 不適用 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000, ...
机构风向标 | ST未名(002581)2025年三季度已披露前十大机构持股比例合计下跌1.31个百分点
Xin Lang Cai Jing· 2025-10-29 03:03
Core Points - ST Unimed (002581.SZ) released its Q3 2025 financial report on October 29, 2025 [1] - As of October 28, 2025, six institutional investors disclosed holdings in ST Unimed A-shares, totaling 139 million shares, which represents 21.07% of the total share capital [1] - The institutional investors include Xiamen Hengxing Group Co., Ltd., Shenzhen Jialian Private Securities Investment Fund Management Co., Ltd. - Jialian No. 1 Securities Investment Fund, Shenzhen Yilian Technology Co., Ltd., Shenzhen Juyunlai Investment Partnership (Limited Partnership), Beijing Peking University Unimed Bioengineering Group Co., Ltd., and Shenwan Hongyuan Securities Co., Ltd. [1] - The total institutional holding percentage decreased by 1.31 percentage points compared to the previous quarter [1] - In terms of public funds, 13 public funds were not disclosed in this period compared to the previous quarter, including Southern CSI 1000 ETF, Huaxia CSI 1000 ETF, GF CSI 1000 ETF, Fortune CSI 1000 Index Enhanced A, and China Merchants CSI 1000 Index Enhanced A [1]
*ST围海(002586.SZ)预中标3.13亿元淮河入海水道相关工程项目
智通财经网· 2025-10-13 08:32
Core Viewpoint - Company *ST Weihai (002586.SZ) has been identified as the preferred bidder for the "Huaihe River to Sea Waterway Phase II Project (within Huai'an City) River Engineering Construction Package 14" with a bid price of 313 million yuan [1] Summary by Category - **Project Details** - The project involves river engineering construction as part of the Huaihe River to Sea Waterway Phase II [1] - The public announcement period for the bid is from October 11, 2025, to October 14, 2025 [1]
*ST围海(002586.SZ):预中标“淮河入海水道二期工程(淮安市境内)河道工程施工14标”项目
Ge Long Hui· 2025-10-13 08:28
Core Points - Company *ST Weihai has been identified as the preferred bidder for the "Huaihe River Estuary Phase II Project (within Huai'an City) River Engineering Construction Lot 14" [1] - The bid amount for the project is 312,956,420.04 yuan, with the final contract amount to be determined upon signing [1] - The public announcement period for this bid is from October 11, 2025, to October 14, 2025 [1]
汤臣集团(00258) - 截至二零二五年九月三十日止之股份发行人的证券变动月报表
2025-10-02 08:46
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 致:香港交易及結算所有限公司 公司名稱: 湯臣集團有限公司(於開曼群島註冊成立之有限公司) 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00258 | 說明 | 不適用 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000,0 ...
汤臣集团(00258) - 致非登记持有人之通知信函及申请表格 – 有关二零二五年度中期报告的刊发通...
2025-09-24 02:39
TOMSON GROUP LIMITED 湯 臣 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號:258) If you for any reason have difficulty in receiving email notification or gaining access to the Websites and would like to receive the Interim Report and all future Corporate Communications2 in printed form, please complete and sign the Request Form on the reverse side of this notification letter and return it to the Company's share registrar in Hong Kong (the "Share Registr ...
汤臣集团(00258) - 致登记股东之通知信函及回条 – 有关二零二五年度中期报告的刊发通知
2025-09-24 02:33
TOMSON GROUP LIMITED 湯 臣 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) (Stock Code 股份代號:258) NOTIFICATION LETTER 通知信函 Dear Registered Shareholder(s), If you for any reason have difficulty in receiving email notification or gaining access to the Websites and would like to receive the Interim Report and all future Corporate Communications in printed form, please complete and sign the Reply Form on the reverse side of this notification letter and return it to the Comp ...
汤臣集团(00258) - 2025 - 中期财报
2025-09-24 02:23
Financial Performance - The Group reported a significant increase in gross profit to HK$1,842,309,000 for the first half of 2025, compared to HK$106,468,000 in 2024, primarily due to the sale proceeds from the first phase of Tomson Foresta[10]. - Consolidated profit after taxation attributable to shareholders reached HK$782,191,000, a 6.55 times increase from HK$103,669,000 in the same period of 2024[11]. - Basic earnings per share increased to 35.96 HK cents, up from 5.03 HK cents in 2024[11]. - Total revenue for the six months ended June 30, 2025, reached HK$2,641,505,000, a significant increase of 1,943% compared to HK$129,565 in 2024[128]. - Gross profit for the same period was HK$1,842,309, representing a 1,634% increase from HK$106,468 in 2024[128]. - Profit for the period was HK$780,882, up 661% from HK$102,631 in 2024[130]. - Total comprehensive income for the period was HK$1,134,672, compared to a loss of HK$188,396 in 2024[130]. Property Development and Investment - The property development and trading segment generated a profit of HK$1,630,223,000, recovering from a loss of HK$28,248,000 in 2024[13]. - The property investment segment contributed a profit of HK$80,239,000, down from HK$93,979,000 in 2024[14]. - Total segment profit from property development and investment was HK$1,710,462,000, compared to HK$65,731,000 in 2024[21]. - Revenue from the property segment amounted to HK$2,615,311,000, accounting for approximately 98.88% of the Group's gross proceeds[22]. - The first phase of Tomson Foresta recognized total revenue of HK$2,512.06 million, representing about 94.98% of the Group's gross proceeds[24]. - Pre-sale proceeds for the second phase of Tomson Foresta reached HK$4,270.36 million, with 143 residential units contracted for sale[25]. - The property development and investment segment contributed a total profit of HK$1,710,462,000 for the six months ending June 30, 2025, compared to HK$65,731,000 in 2024[28]. Cash Flow and Financial Position - As of June 30, 2025, the Group's cash and cash equivalents amounted to HK$1,613,777,000, a decrease of approximately 57.67% from the previous year[66]. - The Group recorded a net cash outflow of HK$848,198,000 from operating activities during the period, primarily due to tax payments and construction costs[66]. - As of June 30, 2025, the Group's total liabilities were HK$4,023,286,000, with approximately 36.51% being borrowings[68]. - The Group's commitments for property development expenditures were HK$2,531,687,000, an increase from HK$2,123,477,000 as of December 31, 2024[70]. - The current ratio improved to 1.79 times from 1.63 times, while the gearing ratio decreased to 67.63% from 74.41%[71]. - Cash and cash equivalents decreased by approximately 57.67% to HK$1,613,777,000 from HK$3,812,642,000[72]. Shareholder Information - Madam Hsu Feng held a total of 971,008,239 shares in the company, representing 42.983% of the total issued shares[96]. - Mr. Albert Tong owned 351,071,985 shares, accounting for 15.541% of the total issued shares[97]. - Mr. Tong Chi Kar Charles held 357,942,326 shares, which is 15.845% of the total issued shares[97]. - King China Holdings Limited owned 308,801,419 shares, representing 13.670% of the total issued shares[103]. - E-Shares Investments Limited held 213,558,771 shares, which is 9.453% of the total issued shares[104]. - Step Famous Investment Limited owned 145,889,287 shares, accounting for 6.458% of the total issued shares[104]. Corporate Governance - The Board has complied with all applicable code provisions of the Corporate Governance Code, except for the dual role of Madam Hsu Feng as both Chairman and Managing Director[117]. - The Audit Committee consists of three independent non-executive Directors, with Mr. Cheung Siu Ping acting as the chairman[121]. - There were no changes in the information regarding the Directors of the Company since the publication of the Annual Report 2024[126]. Future Outlook - The Group remains cautiously optimistic about the long-term economic development in Mainland China despite high interest rates and subdued market sentiment[79]. - Tomson Foresta is expected to be the principal source of profit for the Group in 2025 and a major contributor in the following years[79]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[135]. - Future guidance suggests a focus on enhancing operational efficiency and exploring potential mergers and acquisitions[135].